Atlas FDA

Lava Liquid Embolic System (Lava LES) and Lava Mixing Kit

FDA premarket approval P220020/S007 · decided 2025-08-05

Approval details

PMA number
P220020
Supplement
S007
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Lava Liquid Embolic System (Lava LES) and Lava Mixing Kit
Generic name
Embolization Agent, Vascular
Applicant
Sirtex Medical, Inc.
Date received
2025-05-27
Decision date
2025-08-05
Days to decision
70 days
Decision code
APPR
Product code
QVG
Advisory committee
Cardiovascular
Expedited review
No
Location
Woburn, MA
Statement
Approval for extending the shelf-life to three (3) years

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.